|
1
|
Anton K, Baehring JM and Mayer T:
Glioblastoma multiforme: Overview of current treatment and future
perspectives. Hematol Oncol Clin North Am. 26:825–853. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ostrom QT, Gittleman H, Liao P,
Vecchione-Koval T, Wolinsky Y, Kruchko C and Barnholtz-Sloan JS:
CBTRUS Statistical Report: Primary brain and other central nervous
system tumors diagnosed in the United States in 2010–2014. Neuro
Oncol. 19 (Suppl 5):v1–v88. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 World Health Organization
classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Omuro A and DeAngelis LM: Glioblastoma and
other malignant gliomas: A clinical review. JAMA. 310:1842–1850.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lv M, Shen Y and Yang J, Li S, Wang B,
Chen Z, Li P, Liu P and Yang J: Angiomotin family members:
Oncogenes or tumor suppressors? Int J Biol Sci. 13:772–781. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang T, Zhou Y, Zhang J, Cheng ASL, Yu J,
To KF and Kang W: The physiological role of Motin family and its
dysregulation in tumorigenesis. J Transl Med. 16:982018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lv M, Li S, Luo C, Zhang X, Shen Y, Sui
YX, Wang F, Wang X and Yang J, Liu P and Yang J: Angiomotin
promotes renal epithelial and carcinoma cell proliferation by
retaining the nuclear YAP. Oncotarget. 7:12393–12403. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Moreau J, Lord M, Boucher M, Belleau P and
Fernandes MJG: Protein diversity is generated within the motin
family of proteins by alternative pre-mRNA splicing. Gene.
350:137–148. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim M, Kim M, Park S-J, Lee C and Lim DS:
Role of angiomotin-like 2 mono-ubiquitination on YAP inhibition.
EMBO Rep. 17:64–78. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Han H, Yang B and Wang W: Angiomotin-like
2 interacts with and negatively regulates AKT. Oncogene.
36:4662–4669. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nusse R and Clevers H: Wnt/β-catenin
signaling, disease, and emerging therapeutic modalities. Cell.
169:985–999. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhan T, Rindtorff N and Boutros M: Wnt
signaling in cancer. Oncogene. 36:1461–1473. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vallée A and Lecarpentier Y: Crosstalk
between peroxisome proliferator-activated receptor gamma and the
canonical WNT/β-catenin pathway in chronic inflammation and
oxidative stress during carcinogenesis. Front Immunol. 9:7452018.
View Article : Google Scholar
|
|
14
|
He TC, Sparks AB, Rago C, Hermeking H,
Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW:
Identification of c-MYC as a target of the APC pathway. Science.
281:1509–1512. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brabletz T, Jung A, Dag S, Hlubek F and
Kirchner T: Beta-catenin regulates the expression of the matrix
metalloproteinase-7 in human colorectal cancer. Am J Pathol.
155:1033–1038. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
ten Berge D, Koole W, Fuerer C, Fish M,
Eroglu E and Nusse R: Wnt signaling mediates self-organization and
axis formation in embryoid bodies. Cell Stem Cell. 3:508–518. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Blache P, van de Wetering M, Duluc I,
Domon C, Berta P, Freund JN, Clevers H and Jay P: SOX9 is an
intestine crypt transcription factor, is regulated by the Wnt
pathway, and represses the CDX2 and MUC2 genes. J Cell Biol.
166:37–47. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Clevers H and Nusse R: Wnt/β-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Espada J, Calvo MB, Díaz-Prado S and
Medina V: Wnt signalling and cancer stem cells. Clin Transl Oncol.
11:411–427. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, Qian T, You G, Peng X, Chen C, You
Y, Yao K, Wu C, Ma J, Sha Z, et al: Localizing seizure-susceptible
brain regions associated with low-grade gliomas using voxel-based
lesion-symptom mapping. Neuro Oncol. 17:282–288. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu X, Li Y, Qian Z, Sun Z, Xu K, Wang K,
Liu S, Fan X, Li S, Zhang Z, et al: A radiomic signature as a
non-invasive predictor of progression-free survival in patients
with lower-grade gliomas. Neuroimage Clin. 20:1070–1077. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kanehisa M: The KEGG database. Novartis
Found Symp. 247:91–103, 119-128, 244–252. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang DW, Sherman BT, Tan Q, Collins JR,
Alvord WG, Roayaei J, Stephens R, Baseler MW, Lane HC and Lempicki
RA: The DAVID Gene functional classification tool: A novel
biological module-centric algorithm to functionally analyze large
gene lists. Genome Biol. 8:R1832007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Krieghoff E, Behrens J and Mayr B:
Nucleo-cytoplasmic distribution of beta-catenin is regulated by
retention. J Cell Sci. 119:1453–1463. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jiang WG, Watkins G, Douglas-Jones A,
Holmgren L and Mansel RE: Angiomotin and angiomotin like proteins,
their expression and correlation with angiogenesis and clinical
outcome in human breast cancer. BMC Cancer. 6:162006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cui R, Jiang N, Zhang M, Du S, Ou H, Ge R,
Ma D and Zhang J: AMOTL2 inhibits JUN Thr239 dephosphorylation by
binding PPP2R2A to suppress the proliferation in non-small cell
lung cancer cells. Biochim Biophys Acta Mol Cell Res.
1868:1188582020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guo Z, Wang X, Yang Y, Chen W, Zhang K,
Teng B, Huang C, Zhao Q and Qiu Z: Hypoxic tumor-derived exosomal
long noncoding RNA UCA1 promotes angiogenesis via miR-96-5p/AMOTL2
in pancreatic cancer. Mol Ther Nucleic Acids. 22:179–195. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hong W: Angiomotin'g YAP into the nucleus
for cell proliferation and cancer development. Sci Signal.
6:pe272013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao B, Li L, Lu Q, Wang LH, Liu CY, Lei Q
and Guan KL: Angiomotin is a novel Hippo pathway component that
inhibits YAP oncoprotein. Genes Dev. 25:51–63. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Acebron SP, Karaulanov E, Berger BS, Huang
YL and Niehrs C: Mitotic Wnt signaling promotes protein
stabilization and regulates cell size. Mol Cell. 54:663–674. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Atlasi Y, Noori R, Gaspar C, Franken P,
Sacchetti A, Rafati H, Mahmoudi T, Decraene C, Calin GA, Merrill BJ
and Fodde R: Wnt signaling regulates the lineage differentiation
potential of mouse embryonic stem cells through Tcf3
down-regulation. PLoS Genet. 9:e10034242013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Clevers H, Loh KM and Nusse R: Stem cell
signaling. An integral program for tissue renewal and regeneration:
Wnt signaling and stem cell control. Science. 346:12480122014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Green JL, Inoue T and Sternberg PW:
Opposing Wnt pathways orient cell polarity during organogenesis.
Cell. 134:646–656. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kristensen BW, Priesterbach-Ackley LP,
Petersen JK and Wesseling P: Molecular pathology of tumors of the
central nervous system. Ann Oncol. 30:1265–1278. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
He L, Zhou H, Zeng Z, Yao H, Jiang W and
Qu H: Wnt/β-catenin signaling cascade: A promising target for
glioma therapy. J Cell Physiol. 234:2217–2228. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jung YS and Park JI: Wnt signaling in
cancer: Therapeutic targeting of Wnt signaling beyond β-catenin and
the destruction complex. Exp Mol Med. 52:183–191. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Madan B, Ke Z, Harmston N, Ho SY, Frois
AO, Alam J, Jeyaraj DA, Pendharkar V, Ghosh K, Virshup IH, et al:
Wnt addiction of genetically defined cancers reversed by PORCN
inhibition. Oncogene. 35:2197–2207. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Giraudet AL, Cassier PA, Iwao-Fukukawa C,
Garin G, Badel JN, Kryza D, Chabaud S, Gilles-Afchain L, Clapisson
G, Desuzinges C, et al: A first-in-human study investigating
biodistribution, safety and recommended dose of a new radiolabeled
MAb targeting FZD10 in metastatic synovial sarcoma patients. BMC
Cancer. 18:6462018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jimeno A, Gordon M, Chugh R, Messersmith
W, Mendelson D, Dupont J, Stagg R, Kapoun AM, Xu L, Uttamsingh S,
et al: A first-in-human phase I study of the anticancer stem cell
agent ipafricept (OMP-54F28), a decoy receptor for Wnt ligands, in
patients with advanced solid tumors. Clin Cancer Res. 23:7490–7497.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Patel S, Alam A, Pant R and Chattopadhyay
S: Wnt signaling and its significance within the tumor
microenvironment: Novel therapeutic insights. Front Immunol.
10:28722019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Galluzzi L, Spranger S, Fuchs E and
López-Soto A: WNT signaling in cancer immunosurveillance. Trends
Cell Biol. 29:44–65. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lien WH and Fuchs E: Wnt some lose some:
Transcriptional governance of stem cells by Wnt/β-catenin
signaling. Genes Dev. 28:1517–1532. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Clevers H: Wnt/beta-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
MacDonald BT, Tamai K and He X:
Wnt/beta-catenin signaling: Components, mechanisms, and diseases.
Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
